Public research footprint of The Second Hospital of Lanzhou University, compiled from the ClinicalTrials.gov public registry.
Bladder (Urothelial, Transitional Cell) Cancer · Non-small Cell Lung Cancer · Hepatitis B Virus (HBV) Infection · Progression of Bladder Cancer
Enter your work email to view the full list.
Verify and correct how your facility appears in public registry records — free.
Verify this profile →Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.